2021 Q1 Form 10-Q Financial Statement

#000076889921000102 Filed on April 26, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $458.7M $494.3M
YoY Change -7.19% -10.52%
Cost Of Revenue $348.1M $368.1M
YoY Change -5.42% -9.26%
Gross Profit $110.6M $126.2M
YoY Change -12.35% -14.0%
Gross Profit Margin 24.11% 25.53%
Selling, General & Admin $97.40M $117.4M
YoY Change -17.02% -8.28%
% of Gross Profit 88.09% 93.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.000M $9.100M
YoY Change -23.08% -9.0%
% of Gross Profit 6.33% 7.21%
Operating Expenses $97.40M $117.4M
YoY Change -17.02% -8.28%
Operating Profit $6.211M -$175.5M
YoY Change -103.54% -2102.8%
Interest Expense $1.500M $543.0K
YoY Change 176.24% -24.79%
% of Operating Profit 24.15%
Other Income/Expense, Net $575.0K $263.0K
YoY Change 118.63% -52.44%
Pretax Income $6.786M -$175.2M
YoY Change -103.87% -1981.09%
Income Tax -$112.0K -$24.75M
% Of Pretax Income -1.65%
Net Earnings $6.898M -$150.5M
YoY Change -104.58% -1918.44%
Net Earnings / Revenue 1.5% -30.45%
Basic Earnings Per Share $0.20 -$4.04
Diluted Earnings Per Share $0.20 -$4.04
COMMON SHARES
Basic Shares Outstanding 34.67M shares 37.26M shares
Diluted Shares Outstanding 35.07M shares 37.26M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $88.00M $265.3M
YoY Change -66.83% 908.75%
Cash & Equivalents $88.01M $265.3M
Short-Term Investments
Other Short-Term Assets $10.69M $25.00M
YoY Change -57.22% 2.88%
Inventory
Prepaid Expenses
Receivables $260.1M $293.0M
Other Receivables $6.500M $10.20M
Total Short-Term Assets $384.0M $593.4M
YoY Change -35.29% 53.74%
LONG-TERM ASSETS
Property, Plant & Equipment $76.11M $67.04M
YoY Change 13.53% 15.78%
Goodwill $94.94M $93.29M
YoY Change 1.77% -60.8%
Intangibles $27.10M $34.63M
YoY Change -21.74% -59.98%
Long-Term Investments
YoY Change
Other Assets $17.40M $17.41M
YoY Change -0.07% 7.09%
Total Long-Term Assets $595.4M $541.7M
YoY Change 9.91% -24.13%
TOTAL ASSETS
Total Short-Term Assets $384.0M $593.4M
Total Long-Term Assets $595.4M $541.7M
Total Assets $979.4M $1.135B
YoY Change -13.72% 3.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.20M $39.30M
YoY Change 22.65% -23.54%
Accrued Expenses $140.2M $70.40M
YoY Change 99.15% -13.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $62.00M $69.40M
YoY Change -10.66% -6.34%
Total Short-Term Liabilities $258.5M $187.0M
YoY Change 38.19% -13.13%
LONG-TERM LIABILITIES
Long-Term Debt $26.50M $317.0M
YoY Change -91.64% 651.18%
Other Long-Term Liabilities $3.205M $4.348M
YoY Change -26.29% -2.71%
Total Long-Term Liabilities $3.205M $4.348M
YoY Change -26.29% -90.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $258.5M $187.0M
Total Long-Term Liabilities $3.205M $4.348M
Total Liabilities $533.8M $719.2M
YoY Change -25.78% 43.34%
SHAREHOLDERS EQUITY
Retained Earnings $460.0M $435.8M
YoY Change 5.54% -28.74%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $445.6M $415.9M
YoY Change
Total Liabilities & Shareholders Equity $979.4M $1.135B
YoY Change -13.72% 3.19%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $6.898M -$150.5M
YoY Change -104.58% -1918.44%
Depreciation, Depletion And Amortization $7.000M $9.100M
YoY Change -23.08% -9.0%
Cash From Operating Activities $27.88M $27.61M
YoY Change 1.0% 28.33%
INVESTING ACTIVITIES
Capital Expenditures $10.00M $7.028M
YoY Change 42.33% 19.89%
Acquisitions
YoY Change
Other Investing Activities $6.800M $6.300M
YoY Change 7.94% -13.7%
Cash From Investing Activities -$3.194M -$740.0K
YoY Change 331.62% -152.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $52.35M
YoY Change -100.0% 887.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$2.394M $202.1M
YoY Change -101.18% -556.87%
NET CHANGE
Cash From Operating Activities $27.88M $27.61M
Cash From Investing Activities -$3.194M -$740.0K
Cash From Financing Activities -$2.394M $202.1M
Net Change In Cash $22.56M $227.2M
YoY Change -90.07% -1182.08%
FREE CASH FLOW
Cash From Operating Activities $27.88M $27.61M
Capital Expenditures $10.00M $7.028M
Free Cash Flow $17.88M $20.58M
YoY Change -13.12% 31.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000768899
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-26
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-28
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-14543
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
TrueBlue, Inc.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1287341
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1015 A Street
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tacoma
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98402
CY2021Q1 dei City Area Code
CityAreaCode
253
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
383-9101
CY2021Q1 dei Security12b Title
Security12bTitle
Common stock, no par value
CY2021Q1 dei Trading Symbol
TradingSymbol
TBI
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35471339 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88006000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62507000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2462000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2921000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
260108000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
278343000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29436000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26137000 USD
CY2021Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6461000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
11898000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
384011000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
378885000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76109000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71734000 USD
CY2021Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
231178000 USD
CY2020Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
240534000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
35058000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
30019000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
94937000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
94873000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27101000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28929000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
60101000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
65940000 USD
CY2021Q1 tbi Workers Compensation Claim Receivables Net Of Valuation Allowance
WorkersCompensationClaimReceivablesNetOfValuationAllowance
53547000 USD
CY2020Q4 tbi Workers Compensation Claim Receivables Net Of Valuation Allowance
WorkersCompensationClaimReceivablesNetOfValuationAllowance
52934000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17395000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16729000 USD
CY2021Q1 us-gaap Assets
Assets
979437000 USD
CY2020Q4 us-gaap Assets
Assets
980577000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
48168000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
58447000 USD
CY2021Q1 tbi Employee Related Liabilities Excluding Workers Compensation Liability Current
EmployeeRelatedLiabilitiesExcludingWorkersCompensationLiabilityCurrent
126906000 USD
CY2020Q4 tbi Employee Related Liabilities Excluding Workers Compensation Liability Current
EmployeeRelatedLiabilitiesExcludingWorkersCompensationLiabilityCurrent
122657000 USD
CY2021Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
62005000 USD
CY2020Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
66007000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13308000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13938000 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8102000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7918000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
258489000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
268967000 USD
CY2021Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
191989000 USD
CY2020Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
189486000 USD
CY2021Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
26470000 USD
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
26361000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53657000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54797000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3205000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3776000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
533810000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
543387000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.131
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.131
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35474000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35474000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35493000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35493000 shares
CY2021Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1000 USD
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14332000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14828000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
459958000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
452017000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
445627000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
437190000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
979437000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
980577000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
458706000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
494252000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
348132000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
368093000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
110574000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
126159000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
97401000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
117381000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6962000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9094000 USD
CY2021Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2020Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
175189000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
6211000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-175505000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
575000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
263000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6786000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-175242000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-112000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-24748000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
6898000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-150494000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.04
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.04
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34674000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37255000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35066000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37255000 shares
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
496000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6625000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7394000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-157119000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
6898000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-150494000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6962000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9094000 USD
CY2021Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2020Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
175189000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
207000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3289000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3343000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1508000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5002000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23432000 USD
CY2021Q1 tbi Lease Cost Noncash Expense
LeaseCostNoncashExpense
3920000 USD
CY2020Q1 tbi Lease Cost Noncash Expense
LeaseCostNoncashExpense
3763000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
438000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5375000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18025000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-45407000 USD
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-4910000 USD
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-435000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3501000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4578000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5958000 USD
CY2021Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-9633000 USD
CY2020Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-28443000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
4249000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-11733000 USD
CY2021Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-1499000 USD
CY2020Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-2163000 USD
CY2021Q1 tbi Increase Decreasein Operating Leases Liabilities
IncreaseDecreaseinOperatingLeasesLiabilities
-3320000 USD
CY2020Q1 tbi Increase Decreasein Operating Leases Liabilities
IncreaseDecreaseinOperatingLeasesLiabilities
-3811000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
338000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2334000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27883000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27608000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10003000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7028000 USD
CY2021Q1 tbi Payments To Acquire Restricted Investments Availableforsale Investments
PaymentsToAcquireRestrictedInvestmentsAvailableforsaleInvestments
14000 USD
CY2020Q1 tbi Payments To Acquire Restricted Investments Availableforsale Investments
PaymentsToAcquireRestrictedInvestmentsAvailableforsaleInvestments
1149000 USD
CY2021Q1 tbi Proceeds From Saleand Maturity Of Restricted Investments Availablefor Sale
ProceedsFromSaleandMaturityOfRestrictedInvestmentsAvailableforSale
452000 USD
CY2020Q1 tbi Proceeds From Saleand Maturity Of Restricted Investments Availablefor Sale
ProceedsFromSaleandMaturityOfRestrictedInvestmentsAvailableforSale
1269000 USD
CY2021Q1 tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
6371000 USD
CY2020Q1 tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
6168000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3194000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-740000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
52348000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
255000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
323000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2555000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1792000 USD
CY2021Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
256400000 USD
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-94000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-508000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2394000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
202075000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
262000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1738000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22557000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
227205000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118612000 USD
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4440000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92371000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141169000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
319576000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
477000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
394000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-20000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1751000 USD
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4142000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
702000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
322000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1453000 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2422000 USD
CY2021Q1 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
26745000 USD
CY2020Q4 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
26025000 USD
CY2021Q1 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
25586000 USD
CY2020Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
29410000 USD
CY2021Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
145244000 USD
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
152247000 USD
CY2021Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
5821000 USD
CY2020Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
5915000 USD
CY2021Q1 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
26950000 USD
CY2020Q4 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
26267000 USD
CY2021Q1 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
832000 USD
CY2020Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
670000 USD
CY2021Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
231178000 USD
CY2020Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
240534000 USD
CY2021Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
145244000 USD
CY2021Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
4968000 USD
CY2021Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
276000 USD
CY2021Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
149936000 USD
CY2020Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
152247000 USD
CY2020Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
6090000 USD
CY2020Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
41000 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-877000 USD
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4841000 USD
CY2020Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
158296000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2921000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4288000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
207000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3289000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
669000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1699000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
-3000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
23000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2462000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6379000 USD
CY2021Q1 tbi Prepaid Software Agreements Current
PrepaidSoftwareAgreementsCurrent
9637000 USD
CY2020Q4 tbi Prepaid Software Agreements Current
PrepaidSoftwareAgreementsCurrent
8643000 USD
CY2021Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
9105000 USD
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
8631000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
10694000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8863000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29436000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26137000 USD
CY2021Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
58230000 USD
CY2020Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
55420000 USD
CY2021Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
68676000 USD
CY2020Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
67237000 USD
CY2021Q1 tbi Employee Related Liabilities Excluding Workers Compensation Liability Current
EmployeeRelatedLiabilitiesExcludingWorkersCompensationLiabilityCurrent
126906000 USD
CY2020Q4 tbi Employee Related Liabilities Excluding Workers Compensation Liability Current
EmployeeRelatedLiabilitiesExcludingWorkersCompensationLiabilityCurrent
122657000 USD
CY2021Q1 tbi Workers Compensation Claim Deductible Limit
WorkersCompensationClaimDeductibleLimit
2000000.0 USD
CY2021Q1 tbi Weighted Average Period Claim Payments Below Deductible Limit
WeightedAveragePeriodClaimPaymentsBelowDeductibleLimit
P5Y6M
CY2021Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
271593000 USD
CY2020Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
273502000 USD
CY2021Q1 us-gaap Workers Compensation Discount Amount
WorkersCompensationDiscountAmount
17599000 USD
CY2020Q4 us-gaap Workers Compensation Discount Amount
WorkersCompensationDiscountAmount
18009000 USD
CY2021Q1 tbi Workers Compensation Liability Netof Discount
WorkersCompensationLiabilityNetofDiscount
253994000 USD
CY2020Q4 tbi Workers Compensation Liability Netof Discount
WorkersCompensationLiabilityNetofDiscount
255493000 USD
CY2021Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
62005000 USD
CY2020Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
66007000 USD
CY2021Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
191989000 USD
CY2020Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
189486000 USD
CY2021Q1 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
11200000 USD
CY2020Q1 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
14600000 USD
CY2021Q1 tbi Weighted Average Period Claim Payments And Receivables Above Deductible Limit
WeightedAveragePeriodClaimPaymentsAndReceivablesAboveDeductibleLimit
P17Y
CY2021Q1 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
54600000 USD
CY2020Q4 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
54000000.0 USD
CY2021Q1 tbi Workers Compensation Claim Receivables
WorkersCompensationClaimReceivables
53600000 USD
CY2020Q4 tbi Workers Compensation Claim Receivables
WorkersCompensationClaimReceivables
52900000 USD
CY2021Q1 tbi Workers Compensation Expense
WorkersCompensationExpense
10100000 USD
CY2020Q1 tbi Workers Compensation Expense
WorkersCompensationExpense
14300000 USD
CY2021Q1 tbi Collateral Commitments Cash Collateral Held By Insurance Carriers
CollateralCommitmentsCashCollateralHeldByInsuranceCarriers
22434000 USD
CY2020Q4 tbi Collateral Commitments Cash Collateral Held By Insurance Carriers
CollateralCommitmentsCashCollateralHeldByInsuranceCarriers
22253000 USD
CY2021Q1 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
25586000 USD
CY2020Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
29410000 USD
CY2021Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
145244000 USD
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
152247000 USD
CY2021Q1 tbi Collateral Commitments Lettersof Credit
CollateralCommitmentsLettersofCredit
6095000 USD
CY2020Q4 tbi Collateral Commitments Lettersof Credit
CollateralCommitmentsLettersofCredit
6095000 USD
CY2021Q1 tbi Collateral Commitments Surety Bonds
CollateralCommitmentsSuretyBonds
20831000 USD
CY2020Q4 tbi Collateral Commitments Surety Bonds
CollateralCommitmentsSuretyBonds
20616000 USD
CY2021Q1 tbi Collateral Commitments Total Collateral Commitments
CollateralCommitmentsTotalCollateralCommitments
220190000 USD
CY2020Q4 tbi Collateral Commitments Total Collateral Commitments
CollateralCommitmentsTotalCollateralCommitments
230621000 USD
CY2021Q1 tbi Collateral Commitments Surety Bond Annual Fee Limit Percentage Of Bond Amount
CollateralCommitmentsSuretyBondAnnualFeeLimitPercentageOfBondAmount
0.020
CY2021Q1 tbi Collateral Commitments Surety Bonds Required Cancellation Notice
CollateralCommitmentsSuretyBondsRequiredCancellationNotice
P60D
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
445627000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
415942000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.017
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
6898000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-150494000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34674000 shares
CY2021Q1 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
135000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37255000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
392000 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35066000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37255000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.04
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.04
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
345000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
602000 shares
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
458706000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
494252000 USD
CY2021Q1 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
19013000 USD
CY2020Q1 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
9849000 USD
CY2020Q1 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
135000 USD
CY2021Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
673000 USD
CY2020Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
552000 USD
CY2021Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2020Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
175189000 USD
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
70000 USD
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
1308000 USD
CY2021Q1 tbi Government Assistance
GovernmentAssistance
1743000 USD
CY2020Q1 tbi Government Assistance
GovernmentAssistance
0 USD
CY2021Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
1086000 USD
CY2020Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-6133000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6962000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9094000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
6211000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-175505000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
575000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
263000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6786000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-175242000 USD

Files In Submission

Name View Source Status
0000768899-21-000102-index-headers.html Edgar Link pending
0000768899-21-000102-index.html Edgar Link pending
0000768899-21-000102.txt Edgar Link pending
0000768899-21-000102-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbi-20210328.htm Edgar Link pending
tbi-20210328.xsd Edgar Link pending
tbi-20210328_cal.xml Edgar Link unprocessable
tbi-20210328_def.xml Edgar Link unprocessable
tbi-20210328_g1.jpg Edgar Link pending
tbi-20210328_htm.xml Edgar Link completed
tbi-20210328_lab.xml Edgar Link unprocessable
tbi-20210328_pre.xml Edgar Link unprocessable
tbi10k32821ex311.htm Edgar Link pending
tbi10k32821ex321.htm Edgar Link pending
tbi10q32821ex312.htm Edgar Link pending